Coverage of DoveLewis Portland Area Canine Therapy Teams comforting holiday travelers at Portland International Airport notes the dogs also visit OHSU.

Coverage of various Oregon reports related to respiratory illness prevalence notes OHSU’s Dec. 16 forecast predicts COVID-19 hospitalizations will continue to fall and begin to plateau in February or March.

On the COVID, flu, RSV issue: Dana Braner, M.D. as describing the confluence of diseases as the “greatest threat to children’s health in our state that we have seen in the last 30 years.”

The OHSU Knight Cancer Institute is the only cancer center in the Pacific Northwest selected to participate in a National Cancer Institute-led consortium to accelerate cancer drug discovery. Sanjay Malhotra, Ph.D., says: “We want to attract scientists at OHSU and beyond who have clever ideas for new and improved cancer therapies, and provide them the expertise and infrastructure for translating discoveries from the lab to the clinic.”

The OHSU Knight Cancer Institute is the only cancer center in the Pacific Northwest selected to participate in a National Cancer Institute-led consortium to accelerate cancer drug discovery. Sanjay Malhotra, Ph.D., says: “We want to attract scientists at OHSU and beyond who have clever ideas for new and improved cancer therapies, and provide them the expertise and infrastructure for translating discoveries from the lab to the clinic.”

Nature Cancer interviews current American Association for Cancer Research President Lisa Coussens, Ph.D., on a variety of topics, including highlights from the last year and predictions for 2023. On the topic of mentorship, Coussens says: “If with the support of others you were able to move up the career ladder, you have a responsibility to also help those who are following you, so that they also achieve their dreams.”

Eneida Nemecek, M.D., M.B.A., authors a post for Hem Onc Today highlighting a partnership between the American Society for Transplantation and Cellular Therapy and Be The Match-National Marrow Donor Program to address issues related to awareness, poverty and racial/ethnic inequities in bone marrow transplant treatment. She says: “Barriers to access exist through the therapeutic continuum, from the time of diagnosis to referral, time to transplant, and post-transplant care and support.”

OHSU’s Casey Eye Institute is top for its overall ophthalmology program as well as being among the nation’s top ophthalmology organizations for clinical care, graduate medical education and research.

OHSU’s Dec. 16 Oregon hospital forecast indicates the current surge of statewide COVID and RSV hospitalizations have peaked and predicts the flu hospitalization peak will soon follow suit. Peter Graven, Ph.D. says: “While cases appear to have peaked, and we’re expecting cases to decline over the next two months, holiday gatherings continue to present a risk for increased transmission.”

Charles Blanke, M.D., co-authors a study finding clinical trials in adults conducted within the National Cancer Institute’s (NCI’s) National Clinical Trials Network (NCTN) over the last four decades are estimated to have extended the lives of patients with cancer in the U.S. by at least 14.2 million life-years.